openPR Logo
Press release

Investigation announced for Long-Term NYSE: RMED Investors over potential Wrongdoing at Ra Medical Systems, Inc

10-28-2019 09:29 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Ra Medical Systems, Inc. (NYSE: RMED) shares.

An investigation on behalf of current long term investors in Ra Medical Systems, Inc. (NYSE: RMED) shares.

An investigation on behalf of current long-term investors in shares of Ra Medical Systems, Inc. (NYSE: RMED) concerning potential breaches of fiduciary duties by certain directors and officers of Ra Medical Systems, Inc. was announced.

Investors who are current long term investors in Ra Medical Systems, Inc. (NYSE: RMED) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NYSE: RMED stocks follows a lawsuit filed against Ra Medical Systems, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE: RMED stocks, concerns whether certain Ra Medical Systems, directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges that the Defendants failed to disclose to investors that the Company’s evaluation of sales personnel candidates was inadequate, that the Company’s training program for sales personnel was inadequate, that, as a result, the Company could not reasonably assure that its newly hired sales personnel were adequately experienced, that, as a result, the Company would suffer a shortage of qualified sales personnel, that the Company’s manufacturing process could not reasonably support increased catheter production, that, as a result, the Company would suffer production delays, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Ra Medical Systems, Inc. (NYSE: RMED) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term NYSE: RMED Investors over potential Wrongdoing at Ra Medical Systems, Inc here

News-ID: 1857589 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Medical

ECG Analysis System Market Outlook: 2020 The Year On A Positive Note | GE Medica …
DataIntelo report titled Global ECG Analysis System Market provides detailed information and overview about the key influential factors required to make well informed business decision. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of
Medical Tracheostomy Tube Market Overall Study Report 2020-2027 | Players Medtro …
The latest report added by Stratagem Market Insights gives deep insights into the drivers and restraints in the Worldwide Medical Tracheostomy Tube Market. The research report "Global Medical Tracheostomy Tube Market Size and Growth Forecast to 2027" provide a comprehensive take on the overall market. Analysts have carefully evaluated the milestones achieved by the global Medical Tracheostomy Tube market and the current trends that are likely to shape its future.
Global Embolization Particle Market 2019 - Sirtex Medical, Merit Medical, Cook M …
The global "Embolization Particle Market" report delivers a comprehensive and systematic framework of the Embolization Particle market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Embolization Particle market and the research team meticulously analyze the gathered data with the help of various analytical tools and present their opinion based on analysis and calculations. The
Medical Casting & Splinting Market 2019: Top Key players are 3M, DJO Global, BSN …
Medical Casting & Splinting Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13718924 Global Medical Casting & Splinting market 2019 research provides a basic overview of
Global Embolization Particle Industry 2018 - Sirtex Medical, Merit Medical, Cook …
The Global Embolization Particle Industry 2018 Market Research Report is a professional and in-depth study on the current state of the Embolization Particle industry. Firstly, Embolization Particle Market report provides a basic overview of the Embolization Particle industry including definitions, classifications, applications and Embolization Particle industry chain structure. Global Embolization Particle Market analysis is provided for the international market including development history, Embolization Particle industry competitive landscape analysis, and major regions
Global Oxygen Pressure Regulator Market 2017 : Precision Medical, Smiths Medical …
Oxygen Pressure Regulator A market study based on the " Oxygen Pressure Regulator Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Oxygen Pressure Regulator Market 2017’. The research report analyses the historical as well as present performance of the worldwide Oxygen Pressure Regulator industry, and makes predictions on the future status of Oxygen Pressure Regulator market on the basis of this analysis. Get Free